Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 102.84-36.0267.63-48.67-10.49

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is 102.84 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026102.84
Mar2025-36.02
Mar202467.63
Mar2023-48.67
Mar2022-10.49

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2026 102.84
Positive
Mar2025 -36.02
Negative
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,780.4 Cr -3.9% 7.8% 93.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,620.0 Cr -0.2% -5.1% 8.4% Stock Analytics
DIVIS LABORATORIES ₹239,714.0 Cr -3.8% -3.2% 51.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,741.0 Cr -1.7% -7.7% 29.9% Stock Analytics
CIPLA ₹106,061.0 Cr 0.6% -3.8% -11% Stock Analytics
DR REDDYS LABORATORIES ₹101,339.0 Cr 2.9% 4.6% 0.4% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-3.9%

7.8%

93.3%

SENSEX

0.2%

-2.8%

-11.2%


You may also like the below Video Courses